Publicacións en colaboración con investigadores/as de University Hospital of Zurich (4)

2019

  1. Inhibitor of differentiation-1 sustains mutant KRAS-driven progression, maintenance, and metastasis of lung adenocarcinoma via regulation of a FOSL1 network

    Cancer Research, Vol. 79, Núm. 3, pp. 625-638

  2. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity

    Carcinogenesis, Vol. 40, Núm. 2, pp. 324-334

2017

  1. The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche

    Cancer Letters, Vol. 402, pp. 43-51

2015

  1. Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice

    Clinical and Experimental Metastasis, Vol. 32, Núm. 7, pp. 677-687